Eight out of 10 ARV patients alive 5 years later
Routinely collected data estimate mortality in South Africa at five years on ARV treatment to be 10%, however it is generally accepted that routine data under-estimate mortality after starting treatment.
Using the death registry and by following up on a cohort (group) of patients who had been lost to follow-up and could be linked to the death registry via their identity numbers, researchers were able to statistically adjust the estimates, reaching a more reliable mortality estimate of 18% five years after starting ARV treatment.
‘These are figures we would have happily settled on when we started out on the treatment programme,’ said Dr Andrew Boulle, one of the members of the research team.
Boulle said the good outcomes would also have been influenced by the fact that patients were presenting to health facilities in a less severe state than when the treatment programme started.
The data shows that in 2001/2 the average CD4 count (measure of immunity) of a patient presenting for treatment was 55. In 2008/9 this figure had increased to 125.
South Africa’s HIV treatment guidelines stipulate that all patients presenting with a CD4 count below 200 should be placed on ARV treatment. Indications are that the country will soon bring it in line with the World Health Organisation guidelines indicating treatment initiation at a CD4 count of 350.
‘Amid the anxiety around the programme and the perceived chaos because of the high number of patients it is re-assuring to know that by going to the death registry we can ascertain that although we are missing a lot of the deaths, that the programme has resulted in substantial and durable benefits to those accessing it,’ said Boulle.
A comparable cohort in Entebbe, Uganda who had not had access to ART showed a survival rate of 8%, five years down the line.
The South African research included 48 124 adults who started on ART in 8 cohorts between 2001 and 2009.
The average age was just over 34 years, with 65% of those in the cohort women.
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Eight out of 10 ARV patients alive 5 years later
by Health-e News, Health-e News
June 8, 2011